Fig. 5.

Electrophysiological effects of Alzheimer’s disease (AD) and non-neurodegenerative (NN) patient CSF exposure on co-cultured glutamatergic neurons. (a) Timeline of the CSF exposure experiment. (b–d) Bar graphs showing microchannel weighted mean firing rate (WMFR) over time following chronic exposure to CSF from three anonymous Alzheimer’s patients (A1, A2, and A3). (e–f) Bar graphs showing WMFR over time following chronic exposure to CSF from two anonymous non neurodegenerative patients (H1 and H2). (g) Bar graph showing WMFR over time following chronic exposure to control media (BrainPhys). (h–m) WMFR normalization relative to baseline for each condition: (h–j) AD patients (A1, A2, A3), (k–l) NN patients (H1, H2), and (m) control media. (n) WMFR normalization relative to control media for Alzheimer’s patient CSF conditions. (o) WMFR normalization relative to control media for non-neurodegenerative patient CSF conditions. The data were analyzed using a two-way ANOVA to evaluate the effects of 1µ2 and 2µ3 and their interaction in time. Fisher’s Least Significant Difference (LSD) test was used as a post-hoc analysis to compare specific group means. * p-value < 0.05, ** < 0.01, *** < 0.01 and **** < 0.0001. Error bar = SD. CSF: cerebrospinal fluid. MFR: mean firing rate, WMFR : weighted mean firing rate.